Resistance to Ibritumomab in Lymphoma

Codi QR

Resistance to Ibritumomab in Lymphoma

Guardat en:

Dades bibliogràfiques
Autors principals:	Hosono, Makoto, Chatal, Jean-François
Format:	Llibre
Idioma:	English
Publicat:	Springer International Publishing 2020
Matèries:	Biomedicine Cancer Research
Accés en línia:	https://scholar.dlu.edu.vn/thuvienso/handle/DLU123456789/86965
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Thư viện lưu trữ:	Thư viện Trường Đại học Đà Lạt

Ítems similars

Resistance of Targeted Therapies Excluding Antibodies for Lymphomas
per: Ferreri, Andrés J. M.
Publicat: (2020)

Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways
per: Yarden, Yosef, et al.
Publicat: (2020)

Colorectal Cancer. 1st ed. 2018
per: Beaulieu, Jean-François
Publicat: (2020)

Cancer Epigenetics for Precision Medicine . 1st ed. 2018
per: Dumitrescu, Ramona G., et al.
Publicat: (2020)

Urothelial Carcinoma. 1st ed. 2018
per: Schulz, Wolfgang A, et al.
Publicat: (2020)

Multiple Myeloma. 1st ed. 2018
per: Heuck, Christoph, et al.
Publicat: (2020)

MicroRNA and Cancer. 2nd ed. 2018
per: Wu, Wei
Publicat: (2020)

The Retinoblastoma Protein. 1st ed. 2018
per: Santiago-Cardona, Pedro G.
Publicat: (2020)

Prostate Cancer. 1st ed. 2018
per: Culig, Zoran
Publicat: (2020)

Inflammation and Cancer. 1st ed. 2018
per: Jenkins, Brendan J.
Publicat: (2020)

Tumor Organoids. 1st ed. 2018
per: Soker, Shay, et al.
Publicat: (2020)

Esophageal Adenocarcinoma. 1st ed. 2018
per: Lam, Alfred K.
Publicat: (2020)

Energy Balance and Prostate Cancer. 1st ed. 2018
per: Platz, Elizabeth A., et al.
Publicat: (2020)

Cancer Stem Cells. 1st ed. 2018
per: Papaccio, Gianpaolo, et al.
Publicat: (2020)

Bioactive Components, Diet and Medical Treatment in Cancer Prevention
per: Waly, Mostafa I., et al.
Publicat: (2020)

Early Phase Cancer Immunotherapy . 1st ed. 2018
per: Patel, Sandip Pravin, et al.
Publicat: (2020)

Cancer Systems Biology. 1st ed. 2018
per: Stechow, Louise von
Publicat: (2020)

Glioblastoma. 1st ed. 2018
per: Placantonakis, Dimitris G.
Publicat: (2020)

Proteases and Cancer. 1st ed. 2018
per: Cal, Santiago, et al.
Publicat: (2020)

Molecular Determinants of Head and Neck Cancer
per: Burtness, Barbara, et al.
Publicat: (2020)

The Heterogeneity of Cancer Metabolism
per: Le, Anne
Publicat: (2020)

Focus on Gynecologic Malignancies. 1st ed. 2018
per: Berger, Nathan A., et al.
Publicat: (2020)

Reviews of Physiology, Biochemistry and Pharmacology, Vol. 175
per: Nilius, Bernd, et al.
Publicat: (2020)

Targeting the DNA Damage Response for Anti-Cancer Therapy
per: Pollard, John, et al.
Publicat: (2020)

Biomedical Applications of Metals
per: Rai, Mahendra, et al.
Publicat: (2020)

Molecular and Therapeutic actions of Thymoquinone
per: Younus, Hina
Publicat: (2020)

Obesity, Fatty Liver and Liver Cancer
per: Yu, Jun
Publicat: (2020)

Innovations for Next-Generation Antibody-Drug Conjugates
per: Damelin, Marc
Publicat: (2020)

Alcohol and Cancer
per: Vasiliou, Vasilis, et al.
Publicat: (2020)

Recent Trends in Cancer Biology: Spotlight on Signaling Cascades and microRNAs
per: Fayyaz, Sundas, et al.
Publicat: (2020)

Reviews of Physiology, Biochemistry and Pharmacology Vol. 174
per: Nilius, Bernd, et al.
Publicat: (2020)

Role of Tyrosine Kinases in Gastrointestinal Malignancies
per: Nagaraju, Ganji Purnachandra
Publicat: (2020)

Multiscale Modeling and Simulation of Shock Wave-Induced Failure in Materials Science
per: Steinhauser, Martin Oliver
Publicat: (2020)

Small-Animal SPECT Imaging
per: Kupinski, Matthew A., et al.
Publicat: (2020)

D-type Cyclins and Cancer. 1st ed. 2018
per: Hinds, Philip W., et al.
Publicat: (2020)

Current status of cancer research in Asia, the middle east and oter countries
per: Wada, Takeo
Publicat: (1987)

Drug Resistance in Leishmania Parasites
per: Ponte-Sucre, Alicia, et al.
Publicat: (2020)

The biology of cancer
per: Weinberg, Robert A.

Modulating radiation resistance by inhibiting ribonucleotide reductase in cancers with virally or mutationally silenced p53 protein /

Prognosis in advanced cancer
per: Glare, Paul
Publicat: (2008)